Department of Health confirms it will repeat National Cancer Experience Survey

The Department of Health has confirmed that it will be repeating the National Cancer Patient Experience Survey for 2011.  Professor Sir Mike Richards says that this will enable the Department to "identify and build on progress that has already been made and target [its] efforts to continue to improve patients’ experience of NHS cancer care."

The survey will cover all acute and specialist NHS trusts in England that provide adult acute cancer services.  Recently admitted adult patients with a primary diagnosis of cancer will be included, and all cancer types will be included.  The 2011 survey will largely replicate the 2010 survey methodology and questionnaire which was developed by experts in patient experience surveys and cancer patients’ experiences.

Results are due to be published at a national and Trust level in July 2012.  The letter from Professor Sir Mike Richards to Trust Chief Executives outlining the survey is available here.

Page published: Thu 21 July 2011

It is supported by 10 companies:

  • Amgen
  • Astra Zeneca
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Celgene
  • Lilly
  • Novartis
  • Pfizer
  • Roche
  • Sanofi Aventis